VAERS reports by lot

GSK Varicella/Shingles lot T5242: VAERS reports

91 VAERS reports list lot T5242 as a GSK Varicella/Shingles vaccine, received between 2018-02-22 and 2019-04-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
91
Reports
2%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction9827%
General / Systemic (non-local)9526%
Musculoskeletal3810%
Dermatological (non-injection-site)349%
Neurological339%
Gastrointestinal216%
Allergic / Anaphylactic175%
Cardiac / Cardiovascular123%
Respiratory113%
Psychiatric / Neuropsychiatric72%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania7
Texas6
Kentucky5
Massachusetts4
Tennessee4
Virginia4
North Carolina4
Florida4
Maryland3
Connecticut3
Ohio3
Washington3

Reports by month received

2018-022
2018-0315
2018-0432
2018-0525
2018-0611
2018-071
2018-081
2018-101
2018-111
2018-121
2019-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.